NDC 0076-0111

URIBEL

Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate

URIBEL is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Star Pharmaceuticals, Llc. The primary component is Methenamine; Sodium Phosphate, Monobasic, Monohydrate; Phenyl Salicylate; Methylene Blue; Hyoscyamine Sulfate.

Product ID0076-0111_46e3b17c-53c9-6082-e054-00144ff8d46c
NDC0076-0111
Product TypeHuman Prescription Drug
Proprietary NameURIBEL
Generic NameMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2010-08-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameStar Pharmaceuticals, LLC
Substance NameMETHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE
Active Ingredient Strength120 mg/1; mg/1; mg/1; mg/1; mg/1
Pharm ClassesOxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 0076-0111-02

20 POUCH in 1 BOX (0076-0111-02) > 1 CAPSULE in 1 POUCH
Marketing Start Date2010-08-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0076-0111-02 [00076011102]

URIBEL CAPSULE
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-08-01
Inactivation Date2020-01-31

NDC 0076-0111-01 [00076011101]

URIBEL CAPSULE
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-08-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
METHENAMINE120 mg/1

OpenFDA Data

SPL SET ID:fa2cc334-bd86-46cc-bc6a-12c71303f963
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1087367
  • 1087365
  • Pharmacological Class

    • Oxidation-Reduction Activity [MoA]
    • Oxidation-Reduction Agent [EPC]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]

    NDC Crossover Matching brand name "URIBEL" or generic name "Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate"

    NDCBrand NameGeneric Name
    0076-0111URIBELMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    0178-0740URIBELMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    0076-0902PhosphasalMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    44523-742PhosphasalMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    0682-0334Urimar-TMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    79043-334Urimar-Tmethenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate
    54859-701UrinMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    79043-450URO-SPMethenamine, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, and HYOSCYAMINE SULFATE
    0076-0903UstellMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    44523-743UstellMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate

    Trademark Results [URIBEL]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    URIBEL
    URIBEL
    85021830 3959592 Live/Registered
    MISSION PHARMACAL COMPANY
    2010-04-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.